All filters
Slidesets
First report of dolutegravir unbound plasma concentrations during pregnancy in HIV-positive women- Pauline Bollen
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2018
Slidesets
Update on DDI guidelines of the FDA - in vitro- Xinning Yang, PhD
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2018
Slidesets
Update on DDI guidelines of the FDA - in vivo- Kellie Reynolds, PharmD
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2018
Slidesets
How to End the Global HCV Epidemic - the role of injectables- David Thomas, MD, PhD
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2018
Slidesets
Medication safety issues associated with currently used first-line antiretroviral regimens in Uganda- Kay Seden
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2018
Slidesets
Rifabutin (RBT) Decreases Cabotegravir (CAB) Exposure following Oral Co-administration- Patel
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2018
Slidesets
Rifabutin PK and Safety among HIV/TB Coinfected Children Receiving Lopinavir- Holly Rawizza
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2018
Slidesets
Clinical Pharmacology of HIV Pre-Exposure Prophylaxis (PrEP) – Where are we now?- Craig Hendrix
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2018
Slidesets
Population Pharmacokinetics and Pharmacokinetics/Pharmacodynamics of Etravirine in HIV-positive Children Ages 1-<6 Years- Mustafa IBrahim
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2018
Slidesets
Differential brain tissue penetration of antiretrovirals and fluconazole- Katelyn Pastick
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2018
Slidesets
Charles Boucher, MD, PhD- HIV Macroprevention; epidemiology, phylogenic and networks
Presented at:
European Workshop on Healthy Living with HIV 2017
Slidesets
The impact of antiretroviral drugs on cardiovascular health- Jose Lopez-Sendon
Presented at:
European Workshop on Healthy Living with HIV 2017
Slidesets
The impact of antiretroviral drugs on renal function- Bruce Hendry, BM, BCh, MD, PhD
Presented at:
European Workshop on Healthy Living with HIV 2017
Slidesets
Optimizing antiretroviral drugs for the Aging patient- Giovanni Guaraldi, MD
Presented at:
European Workshop on Healthy Living with HIV 2017
Slidesets
15 years Follow Up in a Cohort of Children diagnosed with HIV Cardiomyopathy- Dr. A.M. Tudor
Presented at:
European Workshop on Healthy Living with HIV 2017
Slidesets
Case discussion: Co-morbidities in people living with HIV- Roger Paredes, MD, PhD
Presented at:
European Workshop on Healthy Living with HIV 2017
Slidesets
Case discussion: How do drugs/patients impact need and type of monitoring- Laura Waters, MD, FRCP
Presented at:
European Workshop on Healthy Living with HIV 2017
Slidesets
The future of patient monitoring- Hans-Jürgen Stellbrink, MD
Presented at:
European Workshop on Healthy Living with HIV 2017
Slidesets
Underdiagnosis and suboptimal care of diabetes mellitus in a French HIV-infected cohort in 2016 - Dr. A. Sautereau
Presented at:
European Workshop on Healthy Living with HIV 2017
Slidesets
Case discussion: How do drugs/patients impact need and type of monitoring- Marta Boffito, MD, PhD, FRCP
Presented at:
European Workshop on Healthy Living with HIV 2017
Slidesets
The rate of HIV transmission within serodiscordant heterosexual couples- Dr. A. Tudor
Presented at:
European Workshop on Healthy Living with HIV 2017